Ingevity (NGVT) to Release Quarterly Earnings on Wednesday

Ingevity (NYSE:NGVT - Get Free Report) is projected to release its Q1 2025 earnings data before the market opens on Wednesday, May 7th. Analysts expect Ingevity to post earnings of $0.74 per share and revenue of $299.13 million for the quarter. Ingevity has set its FY 2025 guidance at EPS.

Ingevity (NYSE:NGVT - Get Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.29 by $0.66. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. The firm had revenue of $298.80 million for the quarter, compared to the consensus estimate of $297.40 million. On average, analysts expect Ingevity to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Ingevity Trading Up 1.4 %

Shares of NGVT stock traded up $0.48 on Monday, hitting $35.52. 133,168 shares of the company's stock traded hands, compared to its average volume of 272,777. The company has a debt-to-equity ratio of 6.86, a quick ratio of 1.04 and a current ratio of 1.87. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of -3.01 and a beta of 1.31. The company's fifty day simple moving average is $38.27 and its 200 day simple moving average is $41.76. Ingevity has a one year low of $28.49 and a one year high of $56.28.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on NGVT. BMO Capital Markets raised Ingevity from a "market perform" rating to an "outperform" rating and boosted their target price for the company from $62.00 to $65.00 in a research note on Wednesday, February 26th. Wells Fargo & Company cut their target price on shares of Ingevity from $45.00 to $32.00 and set an "equal weight" rating on the stock in a report on Wednesday, April 9th. Finally, StockNews.com cut shares of Ingevity from a "buy" rating to a "hold" rating in a research report on Saturday, April 12th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, Ingevity has an average rating of "Moderate Buy" and an average target price of $52.20.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.